President Appoints New Members to the National Cancer Advisory Board
- Dr. Marcia Cruz-Correa, associate professor of medicine and biochemistry at the University of Puerto Rico, visiting associate professor of medicine at the Johns Hopkins University, and adjunct associate professor of surgical oncology at the University of Texas M. D. Anderson Cancer Center
- Dr. Kevin J. Cullen, director of the Marlene and Stewart Greenebaum Cancer Center at the University of Maryland, which became an NCI-designated Cancer Center in 2008 under his leadership
- Dr. Jonathan M. Samet, professor and Flora L. Thornton Chair of the Department of Preventive Medicine at the Keck School of Medicine of the University of Southern California (USC) and director of the USC Institute for Global Health
- Dr. Bill Sellers, vice president and global head of oncology for the Novartis Institutes of BioMedical Research, where he oversees small molecule- and antibody-based drug discovery efforts in oncology
- Dr. Olufunmilayo Falusi Olopade, Walter L. Palmer Distinguished Service Professor of medicine and human genetics, associate dean for global health, and director of the Center for Clinical Cancer Genetics at the University of Chicago
The NCAB is an advisory board, mandated as part of the Public Health Service Act, that advises the secretary of the U.S. Department of Health and Human Services and the NCI director on the Institute’s activities, including reviewing and recommending cooperative agreements following technical and scientific peer review.
In his announcement, President Obama stated, “These dedicated individuals bring a wealth of experience and talent to their new roles, and I am proud to have them serve in this Administration. I look forward to working with them in the months and years to come.”
Greenwald Named NCI Associate Director for Prevention
NCI Director Dr. Harold Varmus selected Dr. Peter Greenwald to serve as NCI’s associate director for prevention beginning February 27. Dr. Greenwald will advise the director and other NCI leaders, guide NCI-wide cancer prevention research programs, set research policy and strategic goals, further cancer prevention research training programs, expand NCI collaborations, and serve as an NCI spokesperson and representative on prevention for the NCI director.
Dr. Greenwald joined NCI in 1981 as director of NCI’s Division of Cancer Prevention and Control, where he notably provided leadership against the use of tobacco, and played a role in creating the 5 A Day nutrition education program and the Community Clinical Oncology Program. After a restructuring of the Institute in 1997, he continued as director of the Division of Cancer Prevention (DCP). Under his leadership, NCI conducted research in nutritional science, basic and preclinical prevention studies through first-in-human to phase III clinical trials, biomarker discovery and validation, biometry, and systems approaches to cancer prevention.
Dr. Greenwald received his medical degree from the State University of New York College of Medicine in Syracuse and his master’s degree and doctorate in public health from the Harvard School of Public Health. He is board certified in both internal medicine and preventive medicine. Dr. Greenwald rose to the rank of a two-star rear admiral and assistant surgeon general in the U.S. Public Health Service Commissioned Corps. He retired from the corps to take his new position at NCI.
Dr. Lori Minasian will serve as the acting director of DCP until a permanent division director has been selected.
NCI has launched a free online community of practice linking cancer control practitioners and researchers. The Web site, Research to Reality (R2R): Collaborating for Cancer Control, is designed to extend the work of Cancer Control P.L.A.N.E.T. and facilitate partnerships by engaging individuals and connecting organizations involved in cancer control. Those who are interested can visit the Web site to gather evidence-based information and discuss emerging issues related to the research and practice of cancer control dissemination and implementation.
Research to Reality has several interactive features, including discussion forums, community profiles, an events calendar, and monthly cyber-seminars that provide information about identifying and adapting evidence-based cancer control programs.
The next cyber-seminar, on March 21 from 11:15 a.m. to 12:45 p.m., is a special videocast of the Dissemination and Implementation (D&I) Science Conference panel on international perspectives of D&I. Future plans include a mentorship program that will help a select cohort of public health practitioners build their capacity to identify and implement evidence-based cancer control and prevention interventions, with much of the information to be shared through the online community.